drugset / Trial / NCT06562738
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Phase 4
Recruiting
55 enrolled
The Third People's Hospital of Chengdu
Affiliated Hospital of North Sichuan Medical College · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated, single-arm, prospective clinical study to evaluate the efficacy and safety of heptapopal in the treatment of thrombocytopenia prior to elective surgery
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-01-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hetrombopag | Small molecule | 7.5 mg | Oral |